, Columnist
The Formula for a Mead Johnson Takeover
The infant-formula maker is cheaper now for a buyer like Danone.
This article is for subscribers only.
The start of each year is when deal-watchers such as myself like to ponder transactions we thought would have happened in the prior 12 months but didn't. Are they any more (or less) likely now? Does the rationale still hold true? Do the numbers work?
With that in mind, here's an intriguing one: the perennially speculated takeover target Mead Johnson.